IFN Beta-1b and Ribavirin for Covid-19
Clinical trial NCT04494399 · UNKNOWN
Trial details
- NCT number
- NCT04494399
- Sponsor
- The University of Hong Kong
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-29
- Primary completion
- 2022-07-01
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.